LONDON BROKER RATINGS: Citi ups Bridgepoint; Barclays cuts Centrica
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
Price | 6,610.00p on 27-03-2025 | at 09:28:11
---|---|
Change | -50.00p -0.75% |
Buy | 6,610.00p |
Sell | 6,600.00p |
Buy / Sell SPX Shares |
Last Trade: | Buy 4.00 at 6,610.00p |
Day's Volume: | 6,850 |
Last Close: | 6,660.00p |
Open: | 6,610.00p |
ISIN: | GB00BWFGQN14 |
Day's Range | 6,565.00p - 6,630.00p |
52wk Range: | 6,355.00p - 10,140.00p |
Market Capitalisation: | £4,867m |
VWAP: | 6,587.18532p |
Shares in Issue: | 74m |
Spirax-Sarco (SPX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 4 | 6,610.00p | Automatic Execution |
09:28:11 - 27-Mar-25 |
Buy* | 11 | 6,605.00p | Automatic Execution |
09:27:04 - 27-Mar-25 |
Buy* | 20 | 6,595.00p | Automatic Execution |
09:26:53 - 27-Mar-25 |
Buy* | 63 | 6,595.00p | Automatic Execution |
09:26:53 - 27-Mar-25 |
Buy* | 11 | 6,590.00p | Automatic Execution |
09:26:52 - 27-Mar-25 |
Buy* | 22 | 6,585.00p | Automatic Execution |
09:26:17 - 27-Mar-25 |
Sell* | 18 | 6,580.00p | Automatic Execution |
09:25:05 - 27-Mar-25 |
Buy* | 73 | 6,580.00p | Automatic Execution |
09:25:01 - 27-Mar-25 |
Sell* | 60 | 6,580.00p | Automatic Execution |
09:25:01 - 27-Mar-25 |
Buy* | 70 | 6,580.00p | Automatic Execution |
09:25:01 - 27-Mar-25 |
Spirax-Sarco (SPX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
19th Mar 2025 11:43 am | RNS | Holding(s) in Company |
12th Mar 2025 7:00 am | RNS | Dividend Declaration |
11th Mar 2025 7:00 am | RNS | 2024 Full Year Results |
10th Mar 2025 1:42 pm | RNS | Director/PDMR Shareholding |
10th Feb 2025 2:23 pm | RNS | Director/PDMR Shareholding |
31st Jan 2025 9:00 am | RNS | Board Appointment |
14th Jan 2025 3:00 pm | RNS | Director/PDMR Shareholding |
2nd Jan 2025 7:00 am | RNS | Board Chair Succession |
11th Dec 2024 1:53 pm | RNS | Director/PDMR Shareholding |
27th Nov 2024 4:18 pm | RNS | Director/PDMR Shareholding |